Keywords: |
unclassified drug; dna binding protein; genetics; missense mutation; dna-binding proteins; mutation, missense; mutant protein; letter; protein domain; mouse; animal; mouse mutant; animals; mice; mice, knockout; amino acid substitution; nuclear protein; genetic association; gene product; transcription factor; gene function; mutational analysis; carcinogenesis; transcription factors; nuclear proteins; cancer inhibition; tumor suppressor gene; b cell lymphoma; lymphoma, b-cell; histone-lysine n-methyltransferase; isoleucine; real time polymerase chain reaction; large cell lymphoma; tumor suppressor protein; genetic screening; valine; histone lysine methyltransferase; lymphoma, large-cell, diffuse; prdm2 protein, human; prdm2 protein, mouse; chromosome banding pattern; chromosome deletion 13; prdm2 gene
|